Gunderson Dettmer represented Kernal Biologics on the deal. Kernal Biologics, a Massachusetts-based biotech company, announced its $25 million Series A financing led by Hummingbird Ventures with participation...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here